Report Detail

Request for Sample of this report

Pharma & Healthcare Global Vaccine Adjuvants Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

  • RnM4653874
    • |
  • 05 December, 2025
    • |
  • Global
    • |
  • 108 Pages
    • |
  • GIR
    • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Vaccine Adjuvants market size was valued at US$ 702 million in 2024 and is forecast to a readjusted size of USD 1234 million by 2031 with a CAGR of 8.5% during review period.
An adjuvant is a substance that is formulated as part of a vaccine to enhance its ability to induce protection against infection. Adjuvants are substances added to vaccines to enhance the immunogenicity of highly purified antigens that have insufficient immunostimulatory capabilities, and have been used in human vaccines for more than 90 years. And many vaccines also contain an adjuvant or adjuvant combination: these are substances added to vaccines specifically because of their immune enhancing effects. Adjuvants were initially used to counter the poor immunogenic potential of highly purified antigens. In recent years their role has expanded as our understanding of the immunology of vaccination has grown.
The vaccine adjuvants market is driven by the increasing need for more effective and long-lasting vaccines. Adjuvants are substances added to vaccines to enhance the body’s immune response, making vaccines more effective, especially in cases where the antigen alone may not provide sufficient protection. The growing prevalence of infectious diseases and the rising demand for vaccines to address new and emerging pathogens, such as COVID-19 variants, are fueling the development and adoption of advanced adjuvants. Additionally, ongoing research and development in immunology and biotechnology are leading to the creation of novel adjuvants that improve vaccine efficacy and safety.
One of the main challenges in the vaccine adjuvants market is the complexity and cost associated with developing and producing new adjuvants. The process requires significant investment in research and development, as well as rigorous testing to ensure safety and effectiveness. Additionally, there are regulatory hurdles that must be overcome, as new adjuvants need to meet stringent guidelines before they can be approved for use. Public concerns about vaccine safety and the potential for adverse reactions to adjuvants also pose challenges, as any negative perceptions can impact vaccine acceptance and adoption.
This report is a detailed and comprehensive analysis for global Vaccine Adjuvants market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Vaccine Adjuvants market size and forecasts, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/Kg), 2020-2031
Global Vaccine Adjuvants market size and forecasts by region and country, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/Kg), 2020-2031
Global Vaccine Adjuvants market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/Kg), 2020-2031
Global Vaccine Adjuvants market shares of main players, shipments in revenue ($ Million), sales quantity (MT), and ASP (USD/Kg), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Vaccine Adjuvants
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Vaccine Adjuvants market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GSK, CSL Limited, Croda, SEPPIC, Sanofi, Zhifei Biological, Escon, Huanuotai Biological, Rico Bio, SDA BIO, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Vaccine Adjuvants market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Emulsion Adjuvants
Mineral Adjuvants
Others
Market segment by Application
Human Vaccine
Veterinary Vaccine
Major players covered
GSK
CSL Limited
Croda
SEPPIC
Sanofi
Zhifei Biological
Escon
Huanuotai Biological
Rico Bio
SDA BIO
SPI Pharma
Phibro Animal Health
Vertellus
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Vaccine Adjuvants product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Vaccine Adjuvants, with price, sales quantity, revenue, and global market share of Vaccine Adjuvants from 2020 to 2025.
Chapter 3, the Vaccine Adjuvants competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Vaccine Adjuvants breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Vaccine Adjuvants market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Vaccine Adjuvants.
Chapter 14 and 15, to describe Vaccine Adjuvants sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Vaccine Adjuvants Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Emulsion Adjuvants
    • 1.3.3 Mineral Adjuvants
    • 1.3.4 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Vaccine Adjuvants Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Human Vaccine
    • 1.4.3 Veterinary Vaccine
  • 1.5 Global Vaccine Adjuvants Market Size & Forecast
    • 1.5.1 Global Vaccine Adjuvants Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Vaccine Adjuvants Sales Quantity (2020-2031)
    • 1.5.3 Global Vaccine Adjuvants Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 GSK
    • 2.1.1 GSK Details
    • 2.1.2 GSK Major Business
    • 2.1.3 GSK Vaccine Adjuvants Product and Services
    • 2.1.4 GSK Vaccine Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 GSK Recent Developments/Updates
  • 2.2 CSL Limited
    • 2.2.1 CSL Limited Details
    • 2.2.2 CSL Limited Major Business
    • 2.2.3 CSL Limited Vaccine Adjuvants Product and Services
    • 2.2.4 CSL Limited Vaccine Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 CSL Limited Recent Developments/Updates
  • 2.3 Croda
    • 2.3.1 Croda Details
    • 2.3.2 Croda Major Business
    • 2.3.3 Croda Vaccine Adjuvants Product and Services
    • 2.3.4 Croda Vaccine Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Croda Recent Developments/Updates
  • 2.4 SEPPIC
    • 2.4.1 SEPPIC Details
    • 2.4.2 SEPPIC Major Business
    • 2.4.3 SEPPIC Vaccine Adjuvants Product and Services
    • 2.4.4 SEPPIC Vaccine Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 SEPPIC Recent Developments/Updates
  • 2.5 Sanofi
    • 2.5.1 Sanofi Details
    • 2.5.2 Sanofi Major Business
    • 2.5.3 Sanofi Vaccine Adjuvants Product and Services
    • 2.5.4 Sanofi Vaccine Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Sanofi Recent Developments/Updates
  • 2.6 Zhifei Biological
    • 2.6.1 Zhifei Biological Details
    • 2.6.2 Zhifei Biological Major Business
    • 2.6.3 Zhifei Biological Vaccine Adjuvants Product and Services
    • 2.6.4 Zhifei Biological Vaccine Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Zhifei Biological Recent Developments/Updates
  • 2.7 Escon
    • 2.7.1 Escon Details
    • 2.7.2 Escon Major Business
    • 2.7.3 Escon Vaccine Adjuvants Product and Services
    • 2.7.4 Escon Vaccine Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Escon Recent Developments/Updates
  • 2.8 Huanuotai Biological
    • 2.8.1 Huanuotai Biological Details
    • 2.8.2 Huanuotai Biological Major Business
    • 2.8.3 Huanuotai Biological Vaccine Adjuvants Product and Services
    • 2.8.4 Huanuotai Biological Vaccine Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 Huanuotai Biological Recent Developments/Updates
  • 2.9 Rico Bio
    • 2.9.1 Rico Bio Details
    • 2.9.2 Rico Bio Major Business
    • 2.9.3 Rico Bio Vaccine Adjuvants Product and Services
    • 2.9.4 Rico Bio Vaccine Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Rico Bio Recent Developments/Updates
  • 2.10 SDA BIO
    • 2.10.1 SDA BIO Details
    • 2.10.2 SDA BIO Major Business
    • 2.10.3 SDA BIO Vaccine Adjuvants Product and Services
    • 2.10.4 SDA BIO Vaccine Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 SDA BIO Recent Developments/Updates
  • 2.11 SPI Pharma
    • 2.11.1 SPI Pharma Details
    • 2.11.2 SPI Pharma Major Business
    • 2.11.3 SPI Pharma Vaccine Adjuvants Product and Services
    • 2.11.4 SPI Pharma Vaccine Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.11.5 SPI Pharma Recent Developments/Updates
  • 2.12 Phibro Animal Health
    • 2.12.1 Phibro Animal Health Details
    • 2.12.2 Phibro Animal Health Major Business
    • 2.12.3 Phibro Animal Health Vaccine Adjuvants Product and Services
    • 2.12.4 Phibro Animal Health Vaccine Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.12.5 Phibro Animal Health Recent Developments/Updates
  • 2.13 Vertellus
    • 2.13.1 Vertellus Details
    • 2.13.2 Vertellus Major Business
    • 2.13.3 Vertellus Vaccine Adjuvants Product and Services
    • 2.13.4 Vertellus Vaccine Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.13.5 Vertellus Recent Developments/Updates

3 Competitive Environment: Vaccine Adjuvants by Manufacturer

  • 3.1 Global Vaccine Adjuvants Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Vaccine Adjuvants Revenue by Manufacturer (2020-2025)
  • 3.3 Global Vaccine Adjuvants Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Vaccine Adjuvants by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Vaccine Adjuvants Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Vaccine Adjuvants Manufacturer Market Share in 2024
  • 3.5 Vaccine Adjuvants Market: Overall Company Footprint Analysis
    • 3.5.1 Vaccine Adjuvants Market: Region Footprint
    • 3.5.2 Vaccine Adjuvants Market: Company Product Type Footprint
    • 3.5.3 Vaccine Adjuvants Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Vaccine Adjuvants Market Size by Region
    • 4.1.1 Global Vaccine Adjuvants Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Vaccine Adjuvants Consumption Value by Region (2020-2031)
    • 4.1.3 Global Vaccine Adjuvants Average Price by Region (2020-2031)
  • 4.2 North America Vaccine Adjuvants Consumption Value (2020-2031)
  • 4.3 Europe Vaccine Adjuvants Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Vaccine Adjuvants Consumption Value (2020-2031)
  • 4.5 South America Vaccine Adjuvants Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Vaccine Adjuvants Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Vaccine Adjuvants Sales Quantity by Type (2020-2031)
  • 5.2 Global Vaccine Adjuvants Consumption Value by Type (2020-2031)
  • 5.3 Global Vaccine Adjuvants Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global Vaccine Adjuvants Sales Quantity by Application (2020-2031)
  • 6.2 Global Vaccine Adjuvants Consumption Value by Application (2020-2031)
  • 6.3 Global Vaccine Adjuvants Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Vaccine Adjuvants Sales Quantity by Type (2020-2031)
  • 7.2 North America Vaccine Adjuvants Sales Quantity by Application (2020-2031)
  • 7.3 North America Vaccine Adjuvants Market Size by Country
    • 7.3.1 North America Vaccine Adjuvants Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Vaccine Adjuvants Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Vaccine Adjuvants Sales Quantity by Type (2020-2031)
  • 8.2 Europe Vaccine Adjuvants Sales Quantity by Application (2020-2031)
  • 8.3 Europe Vaccine Adjuvants Market Size by Country
    • 8.3.1 Europe Vaccine Adjuvants Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Vaccine Adjuvants Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Vaccine Adjuvants Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Vaccine Adjuvants Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Vaccine Adjuvants Market Size by Region
    • 9.3.1 Asia-Pacific Vaccine Adjuvants Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Vaccine Adjuvants Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Vaccine Adjuvants Sales Quantity by Type (2020-2031)
  • 10.2 South America Vaccine Adjuvants Sales Quantity by Application (2020-2031)
  • 10.3 South America Vaccine Adjuvants Market Size by Country
    • 10.3.1 South America Vaccine Adjuvants Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Vaccine Adjuvants Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Vaccine Adjuvants Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Vaccine Adjuvants Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Vaccine Adjuvants Market Size by Country
    • 11.3.1 Middle East & Africa Vaccine Adjuvants Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Vaccine Adjuvants Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Vaccine Adjuvants Market Drivers
  • 12.2 Vaccine Adjuvants Market Restraints
  • 12.3 Vaccine Adjuvants Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Vaccine Adjuvants and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Vaccine Adjuvants
  • 13.3 Vaccine Adjuvants Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Vaccine Adjuvants Typical Distributors
  • 14.3 Vaccine Adjuvants Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Vaccine Adjuvants. Industry analysis & Market Report on Vaccine Adjuvants is a syndicated market report, published as Global Vaccine Adjuvants Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031. It is complete Research Study and Industry Analysis of Vaccine Adjuvants market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo